1. Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial;Andre;Lancet Oncol.,2014
2. Using extracellular biomarkers for monitoring efficacy of therapeutics in cancer patients: an update;Beachy;Cancer Immunol. Immunother.,2008
3. A comparison of observational studies and randomized, controlled trials;Benson;Am J. Ophthalmol.,2000
4. Persistent psychological or physical symptoms following endoscopic procedures: an unrecognized post-endoscopy adverse event;Berzin;Dig. Dis. Sci.,2010
5. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework;Biomarkers Definitions Working Group;Clin. Pharmacol. Ther.,2001